Skip to main contentAll people

CAROL LIM

Professor

Molecular Pharmaceutics

Orcid identifier0000-0001-8409-0151 (opens in a new tab)⁠
  • Professor
    Molecular Pharmaceutics
  • Adjunct Professor
    Pharmacology and Toxicology
  • 801-587-9711 (Work)

RESEARCH INTERESTS

  • Targeting of p53 to the Nucleus and Mitochondria for Cancer Therapy
  • Chronic Myeloid Leukemia

GRANTS

  • EXTERNAL GRANT OR CONTRACT
    PRECLINICAL EVALUATION OF NOVEL FUSION GENE THERAPY P53-BAD* FOR THE TREATMENT OF HEPATOCELLULAR CARCINOMA
    1 Dec 2025 - 30 Nov 2026
  • EXTERNAL GRANT OR CONTRACT
    DEGRADATION-RESISTANT P53 DUAL GENE THERAPY AS A LIVER CANCER THERAPEUTIC
    UNIVERSITY OF UTAH RESEARCH FOUNDATION1 Apr 2024 - 31 Mar 2026
    UNIVERSITY OF UTAH RESEARCH FOUNDATION
  • EXTERNAL GRANT OR CONTRACT
    RE-ENGINEERED MITOCHONDRIALLY TARGETED P53 GENE THERAPY FOR LIVER CANCER
    1 Jan 2021 - 31 Dec 2023
  • EXTERNAL GRANT OR CONTRACT
    A LEUKEMIA CELL-SPECIFIC COILED-COIL PROTEIN FOR TREATMENT OF CHRONIC MYELOID LEUKEMIA
    4 Oct 2020 - 31 Dec 2026
  • FELLOWSHIP OR RESIDENCY
    FELLOWSHIP FOR VANDER MAUSE
    AMERICAN FOUNDATION FOR PHARML9 Jan 2019 - 11 Jan 2020
    AMERICAN FOUNDATION FOR PHARML
  • EXTERNAL GRANT OR CONTRACT
    MITOCHONDRIAL DBD
    NIH NATIONAL CANCER INSTITUTE7 Jul 2015 - 31 Dec 2018
    NIH NATIONAL CANCER INSTITUTE
  • EXTERNAL GRANT OR CONTRACT
    SUPER P53 FOR OVARIAN CANCER
    ARMY MEDICAL RESEARCH ACQUISIT1 Jan 2015 - 31 Dec 2017
    ARMY MEDICAL RESEARCH ACQUISIT
  • EXTERNAL GRANT OR CONTRACT
    BYPASSING DOM NEG IN CANCER
    AMERICAN FOUNDATION FOR PHARML9 Jan 2013 - 31 Dec 2014
    AMERICAN FOUNDATION FOR PHARML
  • EXTERNAL GRANT OR CONTRACT
    Simultaneous Targeting of p53 to the Nucleus and Mitochondria for Cancer Therapy
    NIH NATIONAL CANCER INSTITUTE7 Jan 2010 - 31 May 2014
    NIH NATIONAL CANCER INSTITUTE
  • EXTERNAL GRANT OR CONTRACT
    TARGETING SURVIVIN- PROTEASOME
    ARMY MEDICAL RESEARCH ACQUISIT7 Jan 2009 - 31 Dec 2010
    ARMY MEDICAL RESEARCH ACQUISIT
  • EXTERNAL GRANT OR CONTRACT
    Converting an Oncogene to an Apoptotic Factor by Manipulating Signal Sequences
    NIH NATIONAL CANCER INSTITUTE3 Jan 2008 - 31 Jan 2014
    NIH NATIONAL CANCER INSTITUTE
  • EXTERNAL GRANT OR CONTRACT
    TARGETING OF PROTEINS
    NIH NATL INST DIABETES DIGEST7 Jan 2005 - 31 Dec 2008
    NIH NATL INST DIABETES DIGEST
  • EXTERNAL GRANT OR CONTRACT
    CELLULAR KINETICS
    PHARM RES & MANUF OF AMER FNDN1 Jan 2002 - 31 Dec 2003
    PHARM RES & MANUF OF AMER FNDN
  • EXTERNAL GRANT OR CONTRACT
    AGONIST OCCUPIES PRA
    ARMY MED RES MAT COMM7 Jan 2001 - 31 Dec 2002
    ARMY MED RES MAT COMM
  • EXTERNAL GRANT OR CONTRACT
    PROGESTERONE IN LIVING CELLS
    AMER ASSOC OF COLLEGES OF PHAR12 Jan 2000 - 12 Jan 2002
    AMER ASSOC OF COLLEGES OF PHAR
  • EXTERNAL GRANT OR CONTRACT
    CNS DRUG & HIV
    UNIV OF KENTUCKY8 Jan 2000 - 31 Dec 2003
    UNIV OF KENTUCKY